iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Neutropenic Sepsis

Neutropenic Sepsis

Acute management of sepsis in chemotherapy patients.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 August 2025
OncologyHaematologyEmergency Medicine

Clinical Guidelines

CKS: Neutropenic sepsis
National
NICE guideline [CG151]
National
NICE guideline [CG151]: Neutropenic sepsis: prevention and management
National
NICE guideline [CG151]: Neutropenic sepsis: prevention and management in people with cancer
National

Recent iatroX Q&As

  • What are the key clinical signs and symptoms to identify neutropenic sepsis in a chemotherapy patient?Updated: 8/16/2025
  • How should I initiate empirical antibiotic therapy for a patient with suspected neutropenic sepsis?Updated: 8/16/2025
  • What criteria should I use to determine whether a patient with neutropenic sepsis requires hospital admission?Updated: 8/16/2025
  • Which laboratory investigations are essential for the diagnosis and management of neutropenic sepsis?Updated: 8/16/2025
  • What supportive care measures should be implemented for a patient with neutropenic sepsis in a primary care setting?Updated: 8/16/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play